Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight men

被引:13
作者
Chan, DC
Watts, GF
Ng, TWK
Uchida, Y
Sakai, N
Yamashita, S
Barrett, PHR
机构
[1] Univ Western Australia, Sch Med & Pulm, Perth, WA 6847, Australia
[2] Fujirebio Inc, Div Res & Dev, Tokyo, Japan
[3] Osaka Univ, Grad Sch Med, Dept Metab Med, Osaka, Japan
基金
英国医学研究理事会; 美国国家卫生研究院;
关键词
triglyceride-rich lipoproteins; apoB-100; metabolism; obesity; cardiovascular disease;
D O I
10.1016/j.clinbiochem.2005.05.009
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 [基础医学];
摘要
Objective: We examined the association of plasma apolipoprotein (apoB) B-48, remnant-like particle (RLP)-cholesterol and non-HDL cholesterol concentrations with apoB-100 kinetics in overweight-obese men. Methods and results: Very-low density lipoprotein (VLDL), intermediate-density lipoprotein (IDL) and low-density lipoprotein (LDL) apoB-100 kinetics were measured in 53 men (BMI 33 +/- 4 kg/m(2)) using stable isotopes and multicompartmental modeling to estimate production rate (PR) and fractional catabolic rate (FCR). Fasting apoB-48 and RLP-cholesterol concentrations were measured using immunoassays. In univariate regression, apoB-48 and RLP-cholesterol were inversely associated with VLDL-apoB-100 FCR and IDL-apoB-100 FCR (P < 0.01 for all), but not with VLDL-, IDL- and LDL-apoB-100 PRs. Plasma non-HDL-cholesterol concentration was significantly and positively associated with the secretion rate of VLDL-apoB-100 (P < 0.05), and inversely correlated with the FCR of LDL-apoB-100 (P < 0.01). Conclusions: Our findings suggest that in overweight-obese men plasma concentrations of apoB-48, RLP-cholesterol and non-HDL-cholesterol are partly dependent on catabolism of apoB-100 containing lipoproteins. (c) 2005 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:806 / 812
页数:7
相关论文
共 41 条
[1]
Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance [J].
Adeli, K ;
Taghibiglou, C ;
Van Iderstine, SC ;
Lewis, GF .
TRENDS IN CARDIOVASCULAR MEDICINE, 2001, 11 (05) :170-176
[2]
Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity [J].
Chan, DC ;
Watts, GF ;
Mori, TA ;
Barrett, PHR ;
Redgrave, TG ;
Beilin, LJ .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2003, 77 (02) :300-307
[3]
Apolipoprotein B-100 kinetics in visceral obesity: Associations with plasma apolipoprotein C-III concentration [J].
Chan, DC ;
Watts, GF ;
Redgrave, TG ;
Mori, TA ;
Barrett, PHR .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (08) :1041-1046
[4]
Mechanism of action of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on apolipoprotein B-100 kinetics in visceral obesity [J].
Chan, DC ;
Watts, GF ;
Barrett, PHR ;
Mori, TA ;
Beilin, LJ ;
Redgrave, TG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (05) :2283-2289
[5]
Chan DC, 2002, CLIN CHEM, V48, P278
[6]
Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins [J].
Cohn, JS ;
Marcoux, C ;
Davignon, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (10) :2474-2486
[7]
Cooper AD, 1997, J LIPID RES, V38, P2173
[8]
DYSLIPIDEMIA AND OBESITY [J].
DESPRES, JP .
BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1994, 8 (03) :629-660
[9]
REGIONAL DISTRIBUTION OF BODY-FAT, PLASMA-LIPOPROTEINS, AND CARDIOVASCULAR-DISEASE [J].
DESPRES, JP ;
MOORJANI, S ;
LUPIEN, PJ ;
TREMBLAY, A ;
NADEAU, A ;
BOUCHARD, C .
ARTERIOSCLEROSIS, 1990, 10 (04) :497-511
[10]
Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease [J].
Devaraj, S ;
Vega, G ;
Lange, R ;
Grundy, SM ;
Jialal, I .
AMERICAN JOURNAL OF MEDICINE, 1998, 104 (05) :445-450